Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Supergum is an Israeli manufacturer of rubber, plastic, sealing, protective, and CBRN products serving industrial, automotive, defense, medical, and pharmaceutical customers. The company provides engineering, prototyping, testing, and mass-production services, with capabilities spanning rubber injection molding, extrusion, plastic injection, gasket cutting, and LSR processing. In healthcare-related markets, Supergum appears to act primarily as a supplier of components and protective equipment rather than as a drug developer or therapeutics company. Its medical and pharma offering includes specialized rubber and plastic products for regulated manufacturing environments, while its CBRN division markets protective masks and related safety products. Overall, Supergum is best characterized as a commercial advanced materials and manufacturing company with some exposure to healthcare supply and protective equipment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Supergum.